造影剤注入器の世界市場：製品タイプ別、用途別、エンドユーザー別、地域別、2026～2032年

造影剤注入器の世界市場評価～2026～2032年

造影剤注入器の需要増は、心臓撮影、血管造影、CTスキャンなどの低侵襲治療の増加によってもたらされています。造影剤は、内部構造や動脈の可視性を向上させるために、これらの処置で使用されます。造影剤注入技術は、これらの処置がより頻繁に、より高度になるにつれて、正確かつ効率的である必要があります。さらに、正確な診断と患者の安全性が最も重要です。これらの課題を解決するために、造影剤注入器が開発されています。正確な造影剤注入と副作用リスクの低減は、自動注入プロトコル、リアルタイム投与量モニタリング、異なる製剤の造影剤との互換性などの機能によって保証されています。データ管理機能によって注入設定を正確に記録できるため、より正確な診断が可能になり、再手術の必要性を最小限に抑えることができます。市場拡大の原動力として、2024年の市場売上高は20億7,000万米ドルを超え、2032年には35億1,000万米ドルに達すると予測されています。

さらに、造影剤注入器市場は、効率性と安全性という2つの重要な面で技術改良のブームを経験しています。高圧注入器は、造影剤をより速く供給するために開発されており、心臓画像診断のような一刻を争う手術でより良い画質を実現します。より慎重なコントロールが必要なプロセスでは、低圧注入器が正確な流量調節を可能にします。注入速度と制御の他に、自動化されたプロトコールやリアルタイムの投与量モニタリングなどの改良により、精度が向上し、エラーが減少します。さらに、さまざまな造影剤製剤との互換性により、特殊な要件を持つ患者に対する治療の可能性が広がります。これらの複合的な開発により、造影剤注射は医療従事者にとってより安全で効果的な、汎用性の高いツールとなっています。同市場は、2026～2032年にかけて約7.58%のCAGRで成長し、今後数年間で着実に上昇すると予想されます。

造影剤注入器の世界市場定義/概要

造影剤注入器は、X線、CTスキャン、MRIなどの画像診断時に造影剤を血流に送り込むために使用される医療機器です。これらの造影剤は、内部構造を可視化し、これらの画像診断技術の診断精度を向上させるのに役立ちます。造影剤注入器は、正確かつ制御された量の造影剤を血流に送り込み、最適な画質を確保し、患者の不快感を最小限に抑えるように設計されています。

造影剤注入器は、放射線科、循環器科、腫瘍科、神経科、インターベンショナルラジオロジーなど、さまざまな医療専門セグメントで幅広い用途があります。造影剤注入器は、画像診断の際に血管や臓器、その他の構造物の視認性を高めるために使用され、病状の診断やモニタリングに役立ちます。造影剤注入器は、正確で効果的な医療に不可欠なツールです。

安全性と有効性が改善された新しい造影剤の開発により、これらの装置の診断能力は向上します。さらに、他の医療用画像処理技術との統合や人工知能の利用拡大により、造影剤注入器は個別化医療や精密診断においてより重要な役割を果たすようになると考えられます。ヘルスケア技術が進化し続ける中、造影剤注入器は正確で効果的な医療を提供するために不可欠なツールであり続けると考えられます。

世界の慢性疾患患者の増加は、造影剤注入器の世界開発をどのように促進しているか？

世界の造影剤注入器市場は、慢性疾患の有病率の増加と画像診断処置の需要増に牽引され、大きな成長を遂げています。世界保健機関（WHO）の2022年報告書によると、心血管疾患は依然として世界の死因のトップであり、世界の全死亡者の31％を占めています。このような心血管疾患の高い発生率は、画像診断処置の急増につながり、結果として造影剤注入器の需要を押し上げています。

造影剤注入器の技術的進歩も市場成長の主要因です。これらの技術革新は、患者の快適性と安全性を向上させながら、画像診断の効率と精度を高めています。米国食品医薬品局は、2024年の新しい医療用画像診断機器の承認が前年比12%増加すると報告しており、市場における革新的な製品のパイプラインが強固であることを示しています。

世界の高齢者の拡大も造影剤注入器市場の成長に大きく寄与しています。高齢者は、加齢に伴う健康上の問題から、より頻繁な画像診断が必要となることが多いです。国連のWorld Population Prospects 2022報告書によると、65歳以上の人口は2021年の7億6,100万人から2050年には16億人に倍増すると予測されています。

規制遵守と安全性への懸念は、世界の造影剤注入器市場の成長をどのように妨げているか？

世界の造影剤注入器市場は、規制遵守と安全性に関する重大な課題に直面しています。世界中の保健当局が課す厳しい規制により、メーカーは進化する安全基準を満たすために製品を継続的に更新・改善する必要があります。米国食品医薬品局（FDA）の2024年医療機器有害事象報告書によると、2022年に報告された造影剤注入器関連の事故は1,235件で、安全対策強化の継続的な必要性が浮き彫りになりました。

もう1つの課題は、先進的な造影剤注入器に関連する高コストであり、発展途上国や小規模なヘルスケア施設での導入が制限される可能性があります。このコスト障壁は、地域によるヘルスケアの質と診断能力の格差の一因となっています。世界保健機関（WHO）の「2024年世界保健支出データベース」によると、低所得国が医療機器・器具に費やした費用は一人当たり平均わずか40ドルであるのに対し、高所得国では340ドルです。

ヨウ素化造影剤の世界の不足が続いており、造影剤注入器市場に大きな課題をもたらしています。この不足は注入器の使用率に影響し、世界中の画像診断手順に影響を与えます。米国病院協会（American Hospital Association）は2024年5月、調査対象となった病院の78％がヨード化造影剤の不足を中程度から深刻に経験しており、重要な診断処置の遅れにつながっていると報告しました。

目次

第1章 造影剤注入器の世界市場導入

• 市場の導入
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 造影剤注入器の世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 造影剤注入器の世界市場：製品別

• 概要
• 注入器システム
  • CT注入器システム
  • MRI注入器システム
  • 心血管/血管造影用注入器システム
• 消耗品
  • チューブ
  • シリンジ
  • インターベンショナルラジオロジー

第6章 造影剤注入器の世界市場：用途別

• 概要
• 放射線医療
• インターベンショナルカーディオロジー
• インターベンショナルラジオロジー

第7章 造影剤注入器の世界市場：エンドユーザー別

• 概要
• 病院
• 画像診断センター

第8章 造影剤注入器の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他の欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他のアジア太平洋
• その他
  • ラテンアメリカ
  • 中東・アフリカ

第9章 造影剤注入器の世界市場競合情勢

• 概要
• 各社の市場ランキング
• 主要開発戦略

第10章 企業プロファイル

• Bayer HealthCare LLC
• Bracco Group
• Ulrich Medical
• Guerbet Group
• Medtron AG
• Nemoto Kyorindo Co., Ltd.
• Hong Kong Medi Co Limited
• GE Healthcare（GE Company）

第11章 付録

• 関連調査

Global Contrast Media Injectors Market Valuation - 2026-2032

The increasing demand for these injectors is being driven by the increase in minimally invasive treatments such as heart imaging, angiography, and CT scans. Contrast chemicals are used in these procedures to improve the imaging's visibility of interior structures and blood arteries. Contrast media injection technology needs to be accurate and efficient as these procedures become more frequent and sophisticated. Furthermore, Accurate diagnosis and patient safety are of utmost importance. To solve these issues, contrast media injectors are being developed. Accurate contrast delivery and reduced risk of adverse responses are ensured by features including automated injection protocols, real-time dose monitoring, and compatibility with different formulations of contrast media. The ability to precisely record injection settings through data management capabilities makes it possible to make more accurate diagnoses and maybe minimize the need for repeat surgeries, driving market expansion is predicted to push market sales above USD 2.07 Billion in 2024 and reach USD 3.51 Billion by 2032.

Furthermore, The Contrast Media Injectors Market is experiencing a boom in technological improvements on two critical fronts: efficiency and safety. High-pressure injectors are being developed to provide contrast media faster, resulting in better image quality for time-sensitive operations such as cardiac imaging. For processes that require more careful control, low-pressure injectors provide exact flow regulation. Aside from injection speed and control, improvements such as automated protocols and real-time dose monitoring enhance precision and reduce errors. Furthermore, compatibility with different contrast media formulations broadens therapeutic possibilities for individuals with special requirements. These combined developments are making contrast media injection a safer, more effective, and versatile tool for medical professionals. The market is expected to rise steadily in the coming years to grow at a CAGR of about 7.58% from 2026 to 2032.

Global Contrast Media Injectors Market: Definition/ Overview

Contrast media injectors are medical devices used to deliver contrast agents into the bloodstream during imaging procedures such as X-rays, CT scans, and MRIs. These contrast agents help to visualize internal structures and improve the diagnostic accuracy of these imaging techniques. Contrast media injectors are designed to deliver a precise and controlled amount of contrast agent into the bloodstream, ensuring optimal image quality and minimizing patient discomfort.

Contrast media injectors have a wide range of applications in various medical specialties, including radiology, cardiology, oncology, neurology, and interventional radiology. They are used to enhance the visibility of blood vessels, organs, and other structures during imaging procedures, helping to diagnose and monitor medical conditions. Contrast media injectors are essential tools for accurate and effective medical care.

The development of new contrast agents with improved safety and efficacy profiles will enhance the diagnostic capabilities of these devices. Furthermore, integration with other medical imaging technologies and the increasing use of artificial intelligence will enable contrast media injectors to play a more significant role in personalized medicine and precision diagnostics. As healthcare technology continues to evolve, contrast media injectors will remain an essential tool for providing accurate and effective medical care.

How are the Rising Cases of Chronic Diseases Worldwide Fueling the Development of Global Contrast Media Injectors Market?

The global contrast media injectors market is experiencing significant growth, driven by the increasing prevalence of chronic diseases and the rising demand for diagnostic imaging procedures. According to the World Health Organization's 2022 report, cardiovascular diseases remain the leading cause of death globally, accounting for 31% of all deaths worldwide. This high incidence of cardiovascular diseases has led to a surge in diagnostic imaging procedures, consequently boosting the demand for contrast media injectors.

Technological advancements in contrast media injectors are another key driver of market growth. These innovations are enhancing the efficiency and accuracy of diagnostic imaging procedures while improving patient comfort and safety. The U.S. Food and Drug Administration reported a 12% increase in the approval of new medical imaging devices in 2024 compared to the previous year, indicating a robust pipeline of innovative products in the market.

The expanding geriatric population worldwide is also contributing significantly to the growth of the contrast media injectors market. Elderly individuals often require more frequent diagnostic imaging procedures due to age-related health issues. According to the United Nations' World Population Prospects 2022 report, the number of persons aged 65 years or over is projected to double from 761 million in 2021 to 1.6 billion in 2050.

How are the Regulatory Compliance and Safety Concerns Hindering the Global Contrast Media Injectors Market Growth?

The global contrast media injectors market faces significant challenges related to regulatory compliance and safety concerns. Stringent regulations imposed by health authorities worldwide require manufacturers to continually update and improve their products to meet evolving safety standards. According to the U.S. Food and Drug Administration's 2024 report on medical device adverse events, there were 1,235 incidents related to contrast media injectors reported in 2022, highlighting the ongoing need for enhanced safety measures.

Another challenge is the high cost associated with advanced contrast media injectors, which can limit their adoption in developing countries and smaller healthcare facilities. This cost barrier contributes to disparities in healthcare quality and diagnostic capabilities across different regions. The World Health Organization's 2024 Global Health Expenditure Database revealed that low-income countries spent an average of just $40 per capita on medical devices and equipment, compared to $340 in high-income countries.

The ongoing global shortage of iodinated contrast media poses a significant challenge to the contrast media injectors market. This shortage affects the utilization of injectors and impacts diagnostic imaging procedures worldwide. The American Hospital Association reported in May 2024 that 78% of hospitals surveyed were experiencing moderate to severe shortages of iodinated contrast media, leading to delays in critical diagnostic procedures.

Category-Wise Acumens

What are the Features Bolstering the Demand of Injector Systems Segment?

The injector systems segment is currently dominating the global contrast media injectors market, driven by their efficiency, precision, and compatibility with various imaging modalities. According to the U.S. Centers for Medicare & Medicaid Services (CMS), in 2024, there was a 12% increase in reimbursement rates for contrast-enhanced imaging procedures using advanced injector systems, reflecting their growing importance in diagnostic imaging.

The market's growth is further propelled by technological advancements and product innovations. For instance, on February 18, 2024, Medrad, Inc., a subsidiary of Bayer, launched a new AI-powered contrast media injector system that optimizes contrast dosage based on patient-specific parameters, potentially reducing contrast-related adverse events by up to 30% in clinical trials.

What Factors are Responsible to Project the Market Growth of Hospitals Segment?

The hospitals segment currently holds a dominant position in the global contrast media injectors market, driven by their high patient volumes and advanced diagnostic imaging capabilities. According to the American Hospital Association's 2024 Annual Survey, U.S. hospitals performed over 150 million diagnostic imaging procedures in 2022, with a significant portion requiring contrast media injectors. This dominance is further reinforced by hospitals' ability to invest in cutting-edge medical technologies.

The hospital segment's prominence in the contrast media injectors market is also attributed to the increasing prevalence of chronic diseases requiring advanced diagnostic imaging. The Centers for Disease Control and Prevention (CDC) reported in its 2024 National Health Interview Survey that 51.8% of U.S. adults had at least one chronic condition, necessitating regular diagnostic procedures. Hospitals are well-equipped to handle complex cases and emergency situations where rapid, high-quality imaging is crucial.

How are the Rising Cases of Chronic Diseases Worldwide Fueling the Development of Global Contrast Media Injectors Market?

The global contrast media injectors market is experiencing significant growth, driven by the increasing prevalence of chronic diseases and the rising demand for diagnostic imaging procedures. According to the World Health Organization's 2022 report, cardiovascular diseases remain the leading cause of death globally, accounting for 31% of all deaths worldwide. This high incidence of cardiovascular diseases has led to a surge in diagnostic imaging procedures, consequently boosting the demand for contrast media injectors.

Technological advancements in contrast media injectors are another key driver of market growth. These innovations are enhancing the efficiency and accuracy of diagnostic imaging procedures while improving patient comfort and safety. The U.S. Food and Drug Administration reported a 12% increase in the approval of new medical imaging devices in 2024 compared to the previous year, indicating a robust pipeline of innovative products in the market.

The expanding geriatric population worldwide is also contributing significantly to the growth of the contrast media injectors market. Elderly individuals often require more frequent diagnostic imaging procedures due to age-related health issues. According to the United Nations' World Population Prospects 2022 report, the number of persons aged 65 years or over is projected to double from 761 million in 2021 to 1.6 billion in 2050.

How are the Regulatory Compliance and Safety Concerns Hindering the Global Contrast Media Injectors Market Growth?

The global contrast media injectors market faces significant challenges related to regulatory compliance and safety concerns. Stringent regulations imposed by health authorities worldwide require manufacturers to continually update and improve their products to meet evolving safety standards. According to the U.S. Food and Drug Administration's 2024 report on medical device adverse events, there were 1,235 incidents related to contrast media injectors reported in 2022, highlighting the ongoing need for enhanced safety measures.

Another challenge is the high cost associated with advanced contrast media injectors, which can limit their adoption in developing countries and smaller healthcare facilities. This cost barrier contributes to disparities in healthcare quality and diagnostic capabilities across different regions. The World Health Organization's 2024 Global Health Expenditure Database revealed that low-income countries spent an average of just $40 per capita on medical devices and equipment, compared to $340 in high-income countries.

The ongoing global shortage of iodinated contrast media poses a significant challenge to the contrast media injectors market. This shortage affects the utilization of injectors and impacts diagnostic imaging procedures worldwide. The American Hospital Association reported in May 2024 that 78% of hospitals surveyed were experiencing moderate to severe shortages of iodinated contrast media, leading to delays in critical diagnostic procedures.

Category-Wise Acumens

What are the Features Bolstering the Demand of Injector Systems Segment?

The injector systems segment is currently dominating the global contrast media injectors market, driven by their efficiency, precision, and compatibility with various imaging modalities. According to the U.S. Centers for Medicare & Medicaid Services (CMS), in 2024, there was a 12% increase in reimbursement rates for contrast-enhanced imaging procedures using advanced injector systems, reflecting their growing importance in diagnostic imaging.

The market's growth is further propelled by technological advancements and product innovations. For instance, on February 18, 2024, Medrad, Inc., a subsidiary of Bayer, launched a new AI-powered contrast media injector system that optimizes contrast dosage based on patient-specific parameters, potentially reducing contrast-related adverse events by up to 30% in clinical trials.

What Factors are Responsible to Project the Market Growth of Hospitals Segment?

The hospitals segment currently holds a dominant position in the global contrast media injectors market, driven by their high patient volumes and advanced diagnostic imaging capabilities. According to the American Hospital Association's 2024 Annual Survey, U.S. hospitals performed over 150 million diagnostic imaging procedures in 2022, with a significant portion requiring contrast media injectors. This dominance is further reinforced by hospitals' ability to invest in cutting-edge medical technologies.

The hospital segment's prominence in the contrast media injectors market is also attributed to the increasing prevalence of chronic diseases requiring advanced diagnostic imaging. The Centers for Disease Control and Prevention (CDC) reported in its 2024 National Health Interview Survey that 51.8% of U.S. adults had at least one chronic condition, necessitating regular diagnostic procedures. Hospitals are well-equipped to handle complex cases and emergency situations where rapid, high-quality imaging is crucial.

Country/Region-wise

How will the Advanced Healthcare Infrastructure North America Propels the Contrast Media Injectors Market Growth?

North America has maintained its dominance in the global contrast media injectors market, driven by advanced healthcare infrastructure and high adoption rates of medical imaging technologies. According to the U.S. Centers for Medicare & Medicaid Services (CMS), healthcare spending in the United States reached $4.3 trillion in 2022, with a significant portion allocated to diagnostic imaging services. This substantial investment has enabled healthcare facilities to acquire state-of-the-art contrast media injectors and related technologies.

The region's market dominance is further reinforced by the high prevalence of chronic diseases and an aging population, both of which contribute to increased demand for diagnostic imaging procedures. The U.S. Census Bureau projected in its 2024 report that by 2032, all baby boomers will be older than 65, expanding the pool of patients requiring regular medical imaging. For instance, on March 3, 2024, Bracco Diagnostics Inc. launched a new contrast media injector specifically designed for geriatric patients, featuring enhanced safety protocols and ease of use for elderly individuals undergoing diagnostic procedures, further solidifying North America's position at the forefront of the contrast media injectors market.

How the Increasing Healthcare Investments Supports the Market Growth in the Asia-Pacific?

The Asia-Pacific contrast media injectors market is anticipated to grow at a rapid CAGR during the forecast period, driven by increasing healthcare investments and a rising prevalence of chronic diseases. According to the Indian Ministry of Health and Family Welfare, the country's healthcare sector is expected to reach $372 billion by 2025, indicating a surge in medical infrastructure and advanced diagnostic equipment adoption. This growth is further bolstered by the expanding geriatric population and the growing demand for minimally invasive procedures across the region.

Key market players are actively contributing to this growth through strategic initiatives and product innovations. For instance, on March 15, 2024, Bracco Imaging announced the launch of its new EmpowerCTA(R)+ Injector System in Japan, featuring advanced safety protocols and improved workflow efficiency. This move highlights the industry's focus on enhancing patient care and operational effectiveness in the APAC region. The combination of government support, increasing healthcare expenditure, and ongoing technological advancements positions APAC as a prime market for contrast media injectors in the coming years.

Competitive Landscape

The global contrast media injectors market is a dynamic and competitive landscape, with a mix of established players and emerging challengers vying for market share. These players are actively working to strengthen their presence by implementing strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are dedicated to continuously improving their product line to meet the needs of a wide range of customers in different regions.

Some of the key players operating in the global contrast media injectors market include:

Bayer HealthCare LLC, Bracco Group, Ulrich Medical, Guerbet Group, Medtron AG, Nemoto Kyorindo Co., Ltd., Hong Kong Medi Co Limited, GE Healthcare (GE Company).

Latest Developments

In December 2021, Gadopiclenol, a next-generation magnetic resonance imaging (MRI) contrast agent, will be the subject of a global partnership between Guerbet and Bracco Imaging.

In December 2021, to address the demands of hospitals and imaging networks, Qaelum NV established a strategic agreement with Ulrich GmbH & Co. KG in Ulm. This partnership will allow Qaelum to integrate their cutting-edge Contrast Management technology with Ulrich Medical's contrast media injectors.

Contrast Media Injectors Market, By Category

• Type:
• Single-head Injectors
• Dual-head Injectors
• Syringeless Injectors
• Product:
• Injector Systems
• CT injector systems
• MRI injector systems
• Cardiovascular/angiography injector systems
• Consumables
• Tubing
• Syringe
• Interventional Radiology
• Application:
• Radiology
• Interventional Cardiology
• Interventional Radiology
• End-User:
• Radiology
• Interventional Cardiology
• Interventional Radiology
• Others
• Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CONTRAST MEDIA INJECTORS MARKET

• 1.1 Introduction of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL CONTRAST MEDIA INJECTORS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Injector Systems
  • 5.2.1 CT injector systems
  • 5.2.2 MRI injector systems
  • 5.2.3 Cardiovascular/angiography injector systems
• 5.3 Consumables
  • 5.3.1 Tubing
  • 5.3.2 Syringe
  • 5.3.3 Interventional Radiology

6 GLOBAL CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Radiology
• 6.3 Interventional Cardiology
• 6.4 Interventional Radiology

7 GLOBAL CONTRAST MEDIA INJECTORS MARKET, BY END-USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Diagnostic Imaging Centers

8 GLOBAL CONTRAST MEDIA INJECTORS MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East & Africa

9 GLOBAL CONTRAST MEDIA INJECTORS MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Bayer HealthCare LLC
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Bracco Group
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Ulrich Medical
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Guerbet Group
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Medtron AG
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Nemoto Kyorindo Co., Ltd.
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Hong Kong Medi Co Limited
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 GE Healthcare (GE Company)
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments

11 APPENDIX

• 11.1 Related Research